Melanoma. (Record no. 29486)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03461nam a22003017a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241031103116.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241031103506.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241031b |||||||| |||| 00| 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2015946100 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-22538-8 |
| International Standard Book Number | 978-3-319-22539-5 (eBook) |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0927-3042 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Howard L. Kaufman |
| 222 ## - KEY TITLE | |
| Key title | Acad Dermatol acral activity adjuvant advanced melanoma AJCC analysis Ann Surg Oncol antibody antigen associated benign biochemotherapy BRAF inhibitors BRAF-mutant brain metastases carboplatin cells chemotherapy Clin Cancer Res Clin Oncol clinical trials combination confocal confocal microscopy cutaneous melanoma dabrafenib dacarbazine demonstrated dermoscopy detection diagnosis dose Engl evaluation excision gene genetic high-risk imaging immune immunotherapy improved increased inhibition interferon ipilimumab kinase lesions lymph node biopsy lymphadenectomy lymphocytes malignant melanoma MAPK median MEK inhibitor melanoma patients Melanoma Res metastatic disease metastatic melanoma microscopy months mucosal melanoma mutations nevus nodal optical coherence tomography overall survival paclitaxel pathway patients with melanoma patients with metastatic pediatric melanoma peptide phase III trial pigmented prognostic radiotherapy randomized recurrence regimen reported resection response rate sentinel lymph node sentinel node skin cancer SLNB spitzoid stage subtype sun exposure surgical T-cell targeted therapies temozolomide tissue toxicity trametinib treated treatment tumor uveal melanoma vaccines vemurafenib versus vivo |
| 245 ## - TITLE STATEMENT | |
| Title | Melanoma. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London | |
| Name of publisher, distributor, etc. | Springer International Publishing Switzerland | |
| Date of publication, distribution, etc. | 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 413 Pages |
| Extent | Includes References |
| 490 ## - SERIES STATEMENT | |
| Series statement | Cancer Treatment and Research |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the disease is advanced. There has been significant progress in our understanding of the molecular biology, genetics, and immunology of melanoma over the past decade. This has been accompanied by rapid advances in therapeutic strategies for patients with melanoma. This book provides the clinician and the researcher with a broad understanding of the molecular and cellular pathogenesis of melanoma, explores the clinical characteristics and criteria for clinical and pathological staging of the disease, and provides an overview of current and evolving treatment strategies in the adjuvant, metastatic, and preventive settings. The treatment of special populations and rare variants of melanoma that often present particular clinical challenges is also covered. Authored by international experts in melanoma biology and clinical management, this volume concisely explains how to diagnose, treat, and prevent melanoma while reviewing advances in basic science and providing an overview of innovative approaches still under development. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Dermatology, Medical / Clinical Medicine, Medical / Dermatology, Medical / Oncology / General, Medical / Pediatrics, Medical / Surgery / General, Oncology, Pediatrics, Surgery, Medical / Oncology / Skin Cancer, Medicine, Melanoma. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Fuller form of name | Janice M. Mehnert |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="DOI 10.1007/978-3-319-22539-5 ">DOI 10.1007/978-3-319-22539-5 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Coded location qualifier | Total checkouts | Barcode | Date last seen | Copy number | Uniform resource identifier | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/31/2024 | S/OFFICE | 20241031103116.0 | 10/31/2024 | 20241031103116.0 | DOI 10.1007/978-3-319-22539-5 | 10/31/2024 | E-BOOKS |